For the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
- MEDTRONIC ACTIVA DYSTONIA THERAPY Labeling, 4/15/2003
- ACTIVA DYSTONIA THERAPY Executive Summary, Initial April 21, 2014
- MEDTRONIC ACTIVA DYSTONIA THERAPY Executive Summary 2nd Annual Update, March 24, 2015
- MEDTRONIC ACTIVA DYSTONIA THERAPY Executive Summary 3rd Annual Update, April 12, 2016
- Presentation: Medtronicâs Activa Neurostimulator for Dystonia Treatment Humanitarian Device Exemption (HDE) H020007